Clinical Trial Update: Topiramate in Adolescents With Severe Obesity [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topiramate for weight loss in adolescents with severe obesity has completed enrollment with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity
• Obesity

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: University of Minnesota | Conditions: Obesity, Morbid, Obesity | Phase 2 | Status: COMPLETED | Results posted: 2017-07-02